Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-016240
Filing Date
2025-06-09
Accepted
2025-06-09 16:16:09
Documents
1
Period of Report
2025-06-05

Document Format Files

Seq Description Document Type Size
1 form4-06092025_080604.html 4  
1 form4-06092025_080604.xml 4 4155
  Complete submission text file 0001415889-25-016240.txt   5636
Mailing Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005
Business Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005 (650)-822-5500
Annexon, Inc. (Issuer) CIK: 0001528115 (see all company filings)

EIN.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ANNEXON, INC. 180 KIMBALL WAY, SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address
Cockroft Bettina M. (Reporting) CIK: 0001900452 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39402 | Film No.: 251034315